Friday, September, 20, 2019 03:40:32

Contribution By Saipriya Iyer


EHP concludes 1st in-human trial for new MS & SSc oral treatment

California-based cannabinoid science expert Emerald Health Pharmaceuticals has recently announced that it has successfully completed its 1st Phase I in-human clinical study to assess the pharmacokinetics, safety and pharmacodynamics and tentative biomarkers of EHP-101, the leading product candidate which is an oral formulation of a …